Stockreport

BioCardia Announces Activation of CardiAMP Heart Failure II Phase 3 Pivotal Study Recently Approved by FDA [Yahoo! Finance]

BioCardia, Inc.  (BCDA) 
PDF on advancing late-stage cell therapy interventions for cardiovascular disorders, is targeting heart failure and chronic myocardial ischemia as potential indications for [Read more]